Galanthamine hydrobromide from Lycoris sp., >=94% (TLC)

Galanthamine hydrobromide from Lycoris sp., >=94% (TLC)

Application

Galanthamine hydrobromide from Lycoris sp. has been used-as an AChE (acetylcholinesterase) inhibitor and positive control in acetylcholinesterase assay performed to determine the activity of AChE as a positive control in the screening of AChE inhibitorsas a positive control in AChE inhibitory assay performed to determine the AChE-inhibitory activities of pyrithione and related sulfur-containing pyridine N-oxides

Biochem/physiol Actions

Cholinesterase inhibitor; reverses scopolamine-induced amnesia; antimyasthenic.

General description

Galanthamine hydrobromide is a derivative of galanthamine, which is an anticholinestrase alkaloid derived from genus Lycoris (Amaryllidaceae) or snowdrop. This compound is used for the treatment of Alzheimer’;s disease (AD).

Packaging

Bottomless glass bottle. Contents are inside inserted fused cone.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level mp InChI key InChI Manufacturer Form Assay Price Quantity
3591272 Galanthamine hydrobromide from Lycoris sp., >=94% (TLC) 100 270 °C QORVDGQLPPAFRS-XPSHAMGMSA-N 1S/C17H21NO3.BrH/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17;/h3-6,12,14,19H,7-10H2,1-2H3;1H/t12-,14-,17-;/m0./s1
£185.25 (exc VAT) per 10MG
-
+
3591273 Galanthamine hydrobromide from Lycoris sp., >=94% (TLC) 100 270 °C QORVDGQLPPAFRS-XPSHAMGMSA-N 1S/C17H21NO3.BrH/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17;/h3-6,12,14,19H,7-10H2,1-2H3;1H/t12-,14-,17-;/m0./s1
£53.07 (exc VAT) per 2MG
-
+